Clinical Trial Update: Risk of CV Events With EFV vs. EFV-free Regimens

View source ↗

Summary

This completed clinical trial compares the risk of cardiovascular events in people treated with efavirenz-containing regimens versus EFV-free regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Sustiva (efavirenz)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV/AIDS | Status: COMPLETED